Dong Weng

2.3k total citations
61 papers, 1.8k citations indexed

About

Dong Weng is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Physiology. According to data from OpenAlex, Dong Weng has authored 61 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 16 papers in Immunology and 10 papers in Physiology. Recurrent topics in Dong Weng's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (30 papers), Occupational and environmental lung diseases (14 papers) and Sarcoidosis and Beryllium Toxicity Research (8 papers). Dong Weng is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (30 papers), Occupational and environmental lung diseases (14 papers) and Sarcoidosis and Beryllium Toxicity Research (8 papers). Dong Weng collaborates with scholars based in China, United States and Australia. Dong Weng's co-authors include Jie Chen, Fangwei Liu, Ying Chen, Chao Li, Sitong Du, Laiyu Song, Yiping Lu, Huiping Li, Siyi Li and Qiuhong Li and has published in prestigious journals such as PLoS ONE, Chemical Communications and Scientific Reports.

In The Last Decade

Dong Weng

60 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong Weng China 26 1000 424 391 246 220 61 1.8k
Isabelle Guénon France 18 590 0.6× 401 0.9× 485 1.2× 142 0.6× 221 1.0× 21 1.6k
Cecilia M. Prêle Australia 26 962 1.0× 412 1.0× 496 1.3× 201 0.8× 261 1.2× 54 2.3k
Luisa Morales‐Nebreda United States 20 745 0.7× 813 1.9× 689 1.8× 403 1.6× 277 1.3× 35 2.3k
Adam J. Byrne United Kingdom 22 706 0.7× 965 2.3× 518 1.3× 279 1.1× 243 1.1× 60 2.2k
Venkataramana K. Sidhaye United States 27 887 0.9× 491 1.2× 611 1.6× 177 0.7× 314 1.4× 53 2.0k
Anne M. Manicone United States 23 699 0.7× 646 1.5× 712 1.8× 192 0.8× 152 0.7× 39 2.2k
Shin Kawasaki Japan 28 806 0.8× 466 1.1× 576 1.5× 194 0.8× 507 2.3× 51 2.5k
David M. Brass United States 21 1.0k 1.0× 441 1.0× 443 1.1× 122 0.5× 328 1.5× 44 1.9k
Guochao Shi China 26 581 0.6× 474 1.1× 748 1.9× 162 0.7× 437 2.0× 70 1.9k
Delbert R. Dorscheid Canada 29 797 0.8× 609 1.4× 649 1.7× 293 1.2× 712 3.2× 71 2.3k

Countries citing papers authored by Dong Weng

Since Specialization
Citations

This map shows the geographic impact of Dong Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Weng more than expected).

Fields of papers citing papers by Dong Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Weng. The network helps show where Dong Weng may publish in the future.

Co-authorship network of co-authors of Dong Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Weng. A scholar is included among the top collaborators of Dong Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Weng. Dong Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Nuoxin, Haoyuan Wang, Dong Weng, et al.. (2025). Human amniotic mesenchymal stem cells improve patency and regeneration of electrospun biodegradable vascular grafts via anti-thrombogenicity and M2 macrophage polarization. Colloids and Surfaces B Biointerfaces. 250. 114559–114559. 3 indexed citations
2.
Chen, Jiale, Zhang Li, Hongxu Li, et al.. (2025). Serum metabolomics in pulmonary sarcoidosis: metabolic signatures across prognoses. BMC Pulmonary Medicine. 25(1). 373–373.
3.
Wang, Yanyang, Chan Liu, Nuoxin Wang, et al.. (2025). hAMSCs regulate EMT in the progression of experimental pulmonary fibrosis through delivering miR-181a-5p targeting TGFBR1. Stem Cell Research & Therapy. 16(1). 2–2. 2 indexed citations
4.
Luo, Rong-guang, Yifan Wu, Hai‐Wen Lu, et al.. (2024). Th2-skewed peripheral T-helper cells drive B-cells in allergic bronchopulmonary aspergillosis. European Respiratory Journal. 63(5). 2400386–2400386. 8 indexed citations
5.
Wang, Nuoxin, et al.. (2024). Small diameter vascular grafts: progress on electrospinning matrix/stem cell blending approach. Frontiers in Bioengineering and Biotechnology. 12. 1385032–1385032. 3 indexed citations
6.
Yao, Qian, et al.. (2024). Identification and validation of hub differential genes in pulmonary sarcoidosis. Frontiers in Immunology. 15. 1466029–1466029. 1 indexed citations
7.
Wang, Nuoxin, H. Wang, Dong Weng, et al.. (2023). Nanomaterials for small diameter vascular grafts: overview and outlook. Nanoscale Advances. 5(24). 6751–6767. 4 indexed citations
8.
Chang, Meijia, Yuanyuan Wu, Lin Tong, et al.. (2021). Lyophilized powder of mesenchymal stem cell supernatant attenuates acute lung injury through the IL-6–p-STAT3–p63–JAG2 pathway. Stem Cell Research & Therapy. 12(1). 35 indexed citations
9.
10.
Zhang, Zhaowenbin, Dong Weng, Liqin Lu, et al.. (2021). Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics. Bioactive Materials. 6(10). 3194–3206. 26 indexed citations
11.
Zhang, Yuan, et al.. (2020). Serum IL-35 Levels Are Associated With Activity and Progression of Sarcoidosis. Frontiers in Immunology. 11. 977–977. 8 indexed citations
12.
Zhang, Fen, Dong Weng, Yiliang Su, et al.. (2020). Therapeutic effect of subcutaneous injection of low dose recombinant human granulocyte-macrophage colony-stimulating factor on pulmonary alveolar proteinosis. Respiratory Research. 21(1). 1–1. 78 indexed citations
13.
Fan, Ronglei, et al.. (2019). 5.1% efficiency of Si photoanodes for photoelectrochemical water splitting catalyzed by porous NiFe (oxy)hydroxide converted from NiFe oxysulfide. Chemical Communications. 55(84). 12627–12630. 11 indexed citations
14.
Weng, Dong, Haohao Li, Feng Liu, et al.. (2018). 2-aminopurine suppresses the TGF-β1-induced epithelial–mesenchymal transition and attenuates bleomycin-induced pulmonary fibrosis. Cell Death Discovery. 4(1). 17–17. 20 indexed citations
15.
Hu, Yang, Yan Li, Qiuhong Li, et al.. (2017). Effects of particulate matter from straw burning on lung fibrosis in mice. Environmental Toxicology and Pharmacology. 56. 249–258. 38 indexed citations
16.
Liu, Fangwei, Xiaowei Lu, Yiping Lu, et al.. (2017). IL-10-Producing B Cells Regulate T Helper Cell Immune Responses during 1,3-β-Glucan-Induced Lung Inflammation. Frontiers in Immunology. 8. 414–414. 9 indexed citations
17.
Li, Chao, Sitong Du, Yiping Lu, et al.. (2016). Blocking the 4-1BB Pathway Ameliorates Crystalline Silica-induced Lung Inflammation and Fibrosis in Mice. Theranostics. 6(12). 2052–2067. 47 indexed citations
18.
Li, Huiping, Shanmei Wang, Xian He, et al.. (2015). A novel nanobody specific for respiratory surfactant protein A has potential for lung targeting. International Journal of Nanomedicine. 10. 2857–2857. 13 indexed citations
19.
Yang, Hong, et al.. (2014). IL-10 negatively regulates oxLDL-P38 pathway inhibited macrophage emigration. Experimental and Molecular Pathology. 97(3). 590–599. 5 indexed citations
20.
Chen, Ying, Cuiying Li, Dong Weng, et al.. (2013). Neutralization of interleukin-17A delays progression of silica-induced lung inflammation and fibrosis in C57BL/6 mice. Toxicology and Applied Pharmacology. 275(1). 62–72. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026